ACE2 and COVID-19: Much confusion regarding the upregulation of ACE-2 in COVID-19 comes from the presence of sACE-2 in circulation, presumably due to a compensatory response or dimerization of ACE-2, which lacks affinity for SARS-CoV-2 binding (Yan et al., 2020).